Iridian Asset Management’s Myriad Genetics MYGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2016
Q3
Sell
-3,215,862
Closed -$98.4M 82
2016
Q2
$98.4M Sell
3,215,862
-1,292,487
-29% -$44.9M 0.91% 42
2016
Q1
$169M Buy
4,508,349
+617,277
+16% +$23.3M 1.44% 29
2015
Q4
$168M Sell
3,891,072
-1,389,236
-26% -$58.7M 1.38% 31
2015
Q3
$198M Sell
5,280,308
-522,777
-9% -$18.6M 1.67% 26
2015
Q2
$197M Buy
5,803,085
+391,520
+7% +$13.3M 1.55% 32
2015
Q1
$192M Buy
5,411,565
+1,432,661
+36% +$51.3M 1.61% 30
2014
Q4
$136M Buy
3,978,904
+593,990
+18% +$21.1M 1.26% 33
2014
Q3
$131M Buy
3,384,914
+688,698
+26% +$25.7M 1.35% 33
2014
Q2
$105M Buy
2,696,216
+128,290
+5% +$4.77M 1.08% 36
2014
Q1
$87.8M Buy
+2,567,926
New +$79.6M 1% 37

Other funds holding MYGN